February 2, 2010 Vol. XXVII, No. 6 Sign up for our FREE PW e-newsletter Home Past Issues Search Register Contact Us Back to Phys Weekly  Through The Pipeline  View Printable Page Topical Agent Treats Knee Osteoarthritis        The FDA has approved a New Drug Application for diclofenac sodium topical solution 1.5% w/w (Pennsaid, Covidien). The topical agent is an NSAID used for the treatment of the signs and symptoms of osteoarthritis of the knee.       Source: Covidien.        REFERENCE LINKS: For more on the approval, go to http://investor.covidien.com.   To get Physician's Weekly posted in your hospital, click HERE PW Archives | Past Issues | Register | Contact Us | Search Archive | Back To Top © 2010 Physician’s Weekly, LLC Web design and development by Spindustry Interactive™